Weekend reads: World’s most prolific peer reviewer; replication backlash carries on; controversial PACE study re-analyzed
The week at Retraction Watch featured news of a fine for a doctor who took part in a controversial fake trial, and a likely unprecedented call for retraction by the U.S. FDA commissioner. Here’s what was happening elsewhere: